Despite the small sample size that often complicates research into diseases that affect children, recent genome sequencing efforts have made astounding progress in discovering the underlying genetic causes of pediatric diseases, many of which were previously unpredicted. This Select highlights recent genetic findings that provide clear insights into disease mechanisms and therapeutic targets that will open new vistas of treatment development for diseases that affect young children and adolescents
Pediatric high-grade gliomas (pHGG) are a molecularly diverse group of malignancies, each incredibly...
Medulloblastoma is the most common malignant pediatric brain tumour. Although survival rates have i...
Tumors arising in the central nervous system (CNS) are the largest group of solid tumors affecting c...
Despite the small sample size that often complicates research into diseases that affect children, re...
Central nervous system (CNS) tumors are the most common solid tumor in pediatrics, accounting for ap...
Gliomas are the most common primary brain tumors in children and adults, consisting of astrocytomas,...
The most common pediatric brain tumors are low-grade gliomas (LGGs). We used whole-genome sequencing...
Survival rates for pediatric cancer have significantly increased the past decades, now exceeding 70-...
Pediatric cancers are different from adult cancers in that they often have few targetable DNA mutati...
Molecular profiling is revolutionizing cancer diagnostics and leading to personalized therapeutic ap...
We collated data from 157 unpublished cases of pediatric high-grade glioma and diffuse intrinsic pon...
Childhood brain cancerEvery year, more than 100 children are diagnosed with brain cancer in the Neth...
As genome-scale technologies begin to unravel the complexity of the equivalent tumors in adults, we ...
AbstractObjectiveThe last two decades have seen major advancements in our understanding of some of t...
Brain tumors are the leading cause of cancer-related mortality and morbidity in the pediatric years....
Pediatric high-grade gliomas (pHGG) are a molecularly diverse group of malignancies, each incredibly...
Medulloblastoma is the most common malignant pediatric brain tumour. Although survival rates have i...
Tumors arising in the central nervous system (CNS) are the largest group of solid tumors affecting c...
Despite the small sample size that often complicates research into diseases that affect children, re...
Central nervous system (CNS) tumors are the most common solid tumor in pediatrics, accounting for ap...
Gliomas are the most common primary brain tumors in children and adults, consisting of astrocytomas,...
The most common pediatric brain tumors are low-grade gliomas (LGGs). We used whole-genome sequencing...
Survival rates for pediatric cancer have significantly increased the past decades, now exceeding 70-...
Pediatric cancers are different from adult cancers in that they often have few targetable DNA mutati...
Molecular profiling is revolutionizing cancer diagnostics and leading to personalized therapeutic ap...
We collated data from 157 unpublished cases of pediatric high-grade glioma and diffuse intrinsic pon...
Childhood brain cancerEvery year, more than 100 children are diagnosed with brain cancer in the Neth...
As genome-scale technologies begin to unravel the complexity of the equivalent tumors in adults, we ...
AbstractObjectiveThe last two decades have seen major advancements in our understanding of some of t...
Brain tumors are the leading cause of cancer-related mortality and morbidity in the pediatric years....
Pediatric high-grade gliomas (pHGG) are a molecularly diverse group of malignancies, each incredibly...
Medulloblastoma is the most common malignant pediatric brain tumour. Although survival rates have i...
Tumors arising in the central nervous system (CNS) are the largest group of solid tumors affecting c...